A clinical trial evaluating an investigational medication for the treatment of early stages of Alzheimer’s Disease.
Join our clinical trial to help advance new treatments to end Alzheimer’s Disease.
IPS Research is currently enrolling participants in a clinical trial for adults with early stages of memory loss and Alzheimer’s Disease. This trial is evaluating whether an investigational medication has an effect on mental abilities impaired by the disease.
Qualified participants must be:
• Are aged 50 to 85 years
• Have had gradual decline in memory performance for at least 1 year
• Have a friend or relative willing to be their study partner throughout the study
Qualified participants may receive:
- Study-related care and study drug at no cost
- Compensation for time and travel